期刊文献+

洛伐他汀对BRCA1高表达MCF-7乳腺癌细胞周期调控蛋白的影响 被引量:2

Effects of lovastatin on the cell cycle regulatory proteins in BRCA1-overexpressing MCF-7 cells and the cell proliferation
下载PDF
导出
摘要 目的 探讨胆固醇合成抑制剂洛伐他汀 (lovastatin ,LOV)对BRCA1基因高表达MCF 7乳腺癌细胞株细胞周期调控蛋白表达的影响。方法 将BRCA1基因进行扩增、鉴定后 ,运用脂质体转染MCF 7乳腺癌细胞 ,通过MTT比色法检测细胞增殖功能 ,RT PCR方法检测细胞周期调控蛋白cyclinD1、cyclinD3、CDK2、CDK4的mRNA以及Westernblot检测cy clinD1、CDK4蛋白表达水平。结果 LOV处理后 ,细胞的增殖能力减弱 ,cyclinD1、cyclinD3、CDK2、CDK4mRNA表达及cy clinD1、CDK4蛋白表达均降低 ,其中 ,以BRCA1基因高表达MCF 7乳腺癌细胞株经LOV处理后变化更为显著。结论 BR CA1基因在LOV诱导的细胞周期蛋白抑制中可能起重要作用 ,其高表达增强了MCF Objective To study the effects of lovastatin (LOV) on cyclinD1, cyclinD3, CDK2, and CDK4 in BRCA1 overexpressing MCF 7 cells and the cell proliferation. Methods After amplification and identification of BRCA1 gene, BRCA1 gene was transfected into MCF 7 cells by liposome transfection. The cell proliferation was detected by MTT chromatometry. The mRNA expressions of cyclinD1, cyclinD3, CDK2, and CDK4 and protein expressions of cyclinD1 and CDK4 were analyzed by reverse transcriptase polymerase chain reaction (RT PCR) and Western blotting, respectively. Results LOV weakened the proliferative capacity of cells, and decreased the mRNA expressions of cyclinD1, cyclinD3, CDK2, and CDK4 and the protein expressions of cyclinD1 and CDK4 in cells. These changes were more significant in the transfected cells than that in the nontransfected cells. Conclusion BRCA1 may play a key role in the inhibition of cell cycle regulatory proteins and the cell proliferation induced by LOV. The overexpression of BRCA1 gene may enhance the sensitivity of MCF 7 cells to LOV and the inhibitory effect of LOV on the proliferation of MCF 7 cells.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2004年第12期1061-1064,共4页 Journal of Third Military Medical University
基金 国家自然科学基金资助项目 ( 30 2 7112 8)~~
关键词 洛伐他汀 细胞周期调控蛋白 MCF-7细胞 细胞增殖 乳腺癌 lovastatin cell cycle regulatory protein MCF-7 cell cell proliferation breast cancer
  • 相关文献

参考文献3

二级参考文献12

  • 1Wang IK, Lin-Shiau SY, Lin JK. Suppression of invasion and MMP-9 expression in NIH 3T3 and v-H-Ras 3T3 fibroblasts by lovastatin through inhibition of ras isoprenylation. Ontology, 2000, 59: 245-254.
  • 2Agarwal B, Halmos B, Feoktistov AS, et al. Mechanism of lovastatin-induced apoptosis in intestinal epithelial cells. Carcinogenesis, 2002,23: 521-528.
  • 3Shibata A, Nagaya T, Imai T, et al. Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells. Breast Cancer Res Treat, 2002, 73: 237-243.
  • 4Birbach A, Gold P, Binder BR, et al. Signaling molecules of the NF-kappa B pathway shuttle constitutively between cytoplasm and nucleus. J Biol Chem, 2002, 277: 10842-10851.
  • 5Gnad R, Kaina B, Fritz G. Rho GTPases are involved in the regulation of NF-kappaB by genotoxic stress. Exp Cell Res, 2001, 264: 244-249.
  • 6Joyce D, Albanese C, Steer J, et al. NF-kappaB and cell-cycle regulation: the cyclin connection. Cytokine Growth Factor Rev, 2001,121 : 73-90.
  • 7Namazie A, Alavi S, Olopade OI, et al. Cyclin D1 amplification and p16 (MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Laryngoscope, 2002, 112: 472-481.
  • 8Li J, Tsai MD. Novel insights into the INK4-CDK4/6-Rb pathway:counter action of gankyrin against INK4 proteins regulates the CDK4-mediated phosphorylation of Rb. Biochemistry, 2002, 41 : 3977-3983.
  • 9Martinez BJ, Ferroel A J, Suarez Y, et al. Dose-dependent effects of lovastatin on cell cycle progression: distinct requirement of cholesterol and non-sterol mevalonate derivatives. Biochim Biophys Acta, 2001,1532: 185-194.
  • 10Natalia M, Arthur JK, Stephen FK, et al. Differential effects of Ras signaling through NF-кB on skeletal myogenesis. Oncogene, 2001, 20:1276-1286.

共引文献52

同被引文献27

  • 1ERL W,HRISTOV M,NEUREUTER M,et al.HMG-CoA reductase inhibitors induce apoptosis in neointima-derived vascular smooth muscle cells[J].Atherosclerosis,2003,169(2):251-258.
  • 2SEVILLA C,JULIAN REYNIER C,EISINGER F,et al.Impact of gene patents on the cost-effective delivery of care:the case of BRCA1 genetic testing[J].Int J Technol Assess Health Care,2003,19(2):287-300.
  • 3ROSEN E M,FAN S,PESTELL R G,et al.BRCA1 gene in breast cancer[J].J Cell Physiol,2003,196(1):19-41.
  • 4SCHLEGEL B P,STARITA L M,PARVIN J D.Overexpression of a protein fragment of RNA helicase A causes inhibition of endogenous BRCA1 function and defects in ploidy and cytokinesis in mammary epithelial cells[J].Oncogene,2003,22(7):983-991.
  • 5TYRER J,DUFFY S W,CUZICK J.A breast cancer prediction model incorporating familial and personal risk factors[J].Stat Med,2004,23(7):1111-1130.
  • 6GITIG D M,KOFF A.Cdk pathway:cyclin-dependent kinases and cyclin-dependent kinase inhibitors[J].Methods Mol Biol,2000,142:109-123.
  • 7DONG Y,SUI L,SUGIMOTO K,et al.Cyclin D1-CDK4 complex,a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas[J].Int J Cancer,2001,95(4):209-215.
  • 8FURUKAWA Y.Cell cycle control genes and hematopoietic cell differentiation[J].Leuk Lymphoma,2002,43(2):225-231.
  • 9WANG A,SCHNEIDER BROUSSARD R,KUMAR A P,et al.Regulation of BRCA1 expression by the Rb-E2F pathway[J].J Biol Chem,2000,275(6):4532-4536.
  • 10MALANDERA S,RIDDERHEIM M,MASBACK A,et al.One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations:results of a prospective study in Southern Sweden[J].Eur J Cancer,2004,40(3):422-428.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部